CBL Patras

Greek supplier of peptide starting materials and intermediates. Operates 10,000+ sqm facility producing high-purity peptide building blocks. Serves international pharma and biotech.

CBL Patras is listed as a CDMO in the peptide supply chain, serving Europe markets from Greece. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.